Rad9 protects cells from topoisomerase poison-induced cell death.
about
A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stabilityTargeting DNA Replication Stress for Cancer TherapyImmunodetection of human topoisomerase I-DNA covalent complexesThe role of checkpoint kinase 1 in sensitivity to topoisomerase I poisonsRad9A is required for G2 decatenation checkpoint and to prevent endoreduplication in response to topoisomerase II inhibitionHeat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine.Chk1 Activation Protects Rad9A from Degradation as Part of a Positive Feedback Loop during Checkpoint Signalling.Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias.Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins.Rad9a is required for spermatogonia differentiation in mice.Prospects for the Use of ATR Inhibitors to Treat Cancer.Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro.Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity.The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia.Permissiveness to form pluripotent stem cells may be an evolutionarily derived characteristic in Mus musculus
P2860
Q24306107-9945759F-9F46-4BB1-B7C9-8EF4B4F7A89BQ26739923-9D7E0C14-6963-4CFD-93B4-AD208BD6C94CQ27324108-02DE0D82-777E-4E51-AE95-E8E9F697CE18Q28306393-F54D9B7D-AFFD-49AB-BB23-BBA4B08E4A9FQ33832728-BEF3B3A1-9869-4C6F-811A-2C64F2369919Q35847836-DEAF9034-03B2-486A-AD03-6BED22D6862BQ35867102-A81E18AF-C3DC-4A86-B9E4-1431FCECEF6BQ36680199-76F02201-513A-48EC-8E29-7D16DC6379CEQ37019406-F70DED6F-48AA-472F-BEC8-28949CF7A64DQ37699242-0C12D074-6DC6-4852-BD05-E00C33823FDEQ38974279-E88CB773-BC13-42B3-B964-004480541412Q39301264-946ADE78-D0F9-4FC6-BB70-5A8A63877980Q40184984-236DFDDD-55C4-4753-A5A9-1574B5B1BE82Q44601913-A1E90607-7FC9-47E8-92D5-F3C28FAFB5EAQ57050573-03DB732E-9075-4C26-A61F-C548E042A036
P2860
Rad9 protects cells from topoisomerase poison-induced cell death.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Rad9 protects cells from topoisomerase poison-induced cell death.
@en
Rad9 protects cells from topoisomerase poison-induced cell death.
@nl
type
label
Rad9 protects cells from topoisomerase poison-induced cell death.
@en
Rad9 protects cells from topoisomerase poison-induced cell death.
@nl
prefLabel
Rad9 protects cells from topoisomerase poison-induced cell death.
@en
Rad9 protects cells from topoisomerase poison-induced cell death.
@nl
P2093
P2860
P356
P1476
Rad9 protects cells from topoisomerase poison-induced cell death.
@en
P2093
Benjamin T Vroman
David Loegering
Howard B Lieberman
Jennifer Hackbarth
Kevin M Hopkins
Larry M Karnitz
Pia Roos-Mattjus
Sonnet J H Arlander
P2860
P304
18641-18647
P356
10.1074/JBC.M313536200
P407
P577
2004-02-25T00:00:00Z